Clinical Profile and Outcomes of Acute Viral Hepatitis in Children: Correlation with Laboratory Parameters
International Journal of Pharmaceutical Quality Assurance · 30.09.2026 · 17 (09)
DOI: 10.25258/ijpqa.17.9.43 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 30.09.2026. Verfasst von Rutika Kumari und 2 weiteren Autor:innen.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Acute viral hepatitis is an important cause of morbidity and hospital admission among children, with a variable clinical spectrum ranging from uncomplicated jaundice to severe hepatic dysfunction and acute liver failure. Correlation of clinical manifestations with laboratory abnormalities may help identify children at risk of complications.
Aim
To evaluate the clinical profile, laboratory characteristics, complications, and outcomes of acute viral hepatitis in children and assess their relationship with disease severity. Methodology: A prospective observational study was conducted over one year in the Department of Pediatrics, Patna Medical College and Hospital, Bihar, India. Forty-seven children aged >1 month to
Zitieren
APA
Kumari, R., Kumari, S., & Kuma, H. (2026). Clinical Profile and Outcomes of Acute Viral Hepatitis in Children: Correlation with Laboratory Parameters. International Journal of Pharmaceutical Quality Assurance, 17(09). https://doi.org/10.25258/ijpqa.17.9.43
Vancouver
Kumari R, Kumari S, Kuma H. Clinical Profile and Outcomes of Acute Viral Hepatitis in Children: Correlation with Laboratory Parameters. International Journal of Pharmaceutical Quality Assurance. 2026;17(09). doi:10.25258/ijpqa.17.9.43
BibTeX
@article{Kumari2026,
author = {Kumari, Rutika and Kumari, Suman and Kuma, Hemant},
title = {Clinical Profile and Outcomes of Acute Viral Hepatitis in Children: Correlation with Laboratory Parameters},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2026},
volume = {17},
number = {09},
doi = {10.25258/ijpqa.17.9.43}
}
EUVIMED